Background: Beta-lactam (BL) antibiotics hypersensitivity is common in children. Clinical manifestation of BL hypersensitivity varies from mild to severe cutaneous adverse drug reactions (SCARs).
Introduction
Beta-lactam (BL) antibiotics including penicillin and cephalosporin antibiotics are commonly used for bacterial infection in children. Approximately 10-20% of children receiving betalactam antibiotics develop hypersensitivity reaction. [1] [2] [3] Drug hypersensitivity reactions can be classified simply as immediate or delayed reaction. Immediate reactions occur within 1 hour after intake of the drug and are often mediated by IgE antibodies. 4 Clinical symptom of immediate reaction can be local organ involvement such as urticaria, angioedema, bronchospasm, induced hypersensitivity. As a result, antibiotics hypersensitivity is over-diagnosed and leading to administration of alternative antibiotic with increasing costs and development of drug resistance due to the increased usage of broad spectrum antibiotics. 6 Recently there is increasing evidence on the role of pharmacogenomics testing in pediatric patients to predict the dose requirement, efficacy and adverse drug reaction. 7 However, ethnicity also has an impact on the genetic frequency. HLA-B* 15 :02 has been demonstrated to have a strong association with carbamazepine induced SJS/TEN in Han Chinese 8 and Thais 9, 10 but not in Japanese or European population. 11 Recommendation to screen for HLA-B*15:02 before prescribing carbamazepine 12, 13 has been used in several Asian countries including Thailand. We have recently demonstrated the role of pharmacogenetics testing in predicting phenytoin hypersensitivity 14 and phenobarbital hypersensitivity. 15, 16 However, there is limited study investigating the association between HLA genotypes and BL hypersensitivity in children. The present study aimed to determine the association of HLA genotype and beta lactam hypersensitivity in children and demonstrated the prevalence of true drug hypersensitivity in patients with history of BL hypersensitivity.
reverse sequence-specific oligonucleotide probes (SSO). The HLA genotyping is typed to 2-fileld (4 digits).
Statistical analysis
Data analysis was performed using SPSS 18.0 software package and R console 3.1.1 statistical software for window (http://cran.r-project.org/). Descriptive statistic were used for demographic data. Genotype carrier rate were compared between the drug allergy group and the drug tolerance group. The associations of HLA alleles/ genotype carrier rate with BL hypersensitivity were determined by Fisher's exact test, and the strength of association was estimated by calculating the odds ratios (ORs) and 95%confidence intervals (CIs). Haplotype association analysis were carried out using 'haplo.stats' packages. The test associations were determined from P-values. ORs and 95% CIs were obtained using inferred counts of haplotypes. A p-value less than 0.05 was considered statistically significant.
Results
One hundred and seventeen subjects were enrolled : 71 children with suspected of BL hypersensitivity who were evaluated for true BL hypersensitivity,15 cases of previously confirmed BL hypersensitivity, 2 cases with the diagnosis of SCARS (1 SJS and 1 DRESS) and 29 children with known BL tolerance. All 71 children who underwent for true BL hypersensitivity had histories of reactions after exposure to BL as follow: 30 with urticaria/angioedema, 3 with anaphylaxis, 37 with maculopapular eruption and 1 with fixed drug eruption. Only 7 (9.8%) out of 71 children with suspected of BL hypersensitivity were confirmed to have BL hypersensitivity (Figure 1) A total of 24 children with confirmed BL hypersensitivity (case) and 93 children with BL tolerance (control) were analyzed in the case control study. There was no significant differences in the mean age between case and control (9.04 ± 4.31 year vs 8.03 ± 4.12 year, p = 0.51). Amoxicillin was the most common cause of true BL hypersensitivity in our study (58.3%), followed by amoxicillin-clavulanic acid (16.7%), ceftriaxone (8.3%), cloxacillin (8.3%), ampicillin/ salbactam (4.2%) and meropenem (4.2%). Fourteen (58.3%) of 24 children had immediate reactions. Urticarial rash appeared in 14 children, two children were diagnosed anaphylaxis, maculopapular eruptions were presented in 5 children and SCARs were diagnosed in 2 cases (1 case with DRESS, 1 case with SJS) ( Table 1) .
Association of HLA genotype Carrier Rates and the BL hypersensitivity
The HLA-A, HLA-B, HLA-C and HLA-DRB1 genotypes of BL hypersensitivity are listed in 
Methods

Subjects
A case-control study was performed in 117 children at Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. Cases were Thai children aged 1-18 years with confirmed diagnosis of BL hypersensitivity defined as positive BL hypersensitivity investigation in addition to having history of suspected BL hypersensitivity or having the diagnosis of SCARs from BL. The diagnosis of SCARs were confirmed by either an allergist or a dermatologist, and their decisions were based on the clinical criteria for SJS/TEN 17 and DRESS. 18 Tolerant controls were healthy Thai children with no allergic reaction to BL drug provocation (drug tolerance). This study was reviewed and approved by the human rights and ethic committee of Faculty of Medicine, Ramathibodi Hospital, Mahidol University (ID 01-57-17).
True BL hypersensitivity investigation
All subjects with suspected BL hypersensitivity without clinical of severe cutaneous adverse drug eruption (SCARs) were evaluated for the confirmation of true BL hypersensitivity as previously reported. 2 Briefly skin prick test was initially performed followed by intradermal skin test if the result of skin prick test was negative. Drug provocation test (DPT) was performed in cases with negative skin test result.
HLA Genotyping
After written informed consent was obtained, the genomic DNA was extracted from the peripheral blood and diluted to 20 ng/μL, according to the established DNA extraction protocol protocols of the manufacturer. The HLA genotype determination and the data analysis was performed by WAKflow software (Wakunaga, Osaka, JAPAN). HLA genotyping was based on the Values presented as N (%), P-value corresponds to Chi-square test or Fisher's exact test. OR, odd ratios were calculated using dominant model; 95%CI, 95% Confident Interval; P, P-value; ns, not significant; * P < 0.050* 
Discussion
We have demonstrated that the prevalence of true BL hypersensitivity is only 9.8% in children who had history of suspected of BL hypersensitivity. This finding was similar to a previous study in 783 patients with symptoms suggestive of BL hypersensitivity. Only 62 cases (7.9 %) were confirmed to have BL hypersensitivity. 19 BL antibiotics are one of the most common drug allergies since they are the most prescribed drugs worldwide. 20 Investigation for drug hypersensitivity reaction require both skin test and drug provocation test. Among 7 children who were confirmed to have BL hypersensitivity reactions in our study, 3 (42.8 %) children were diagnosed by skin tests and 4 (57.2 %) by drug provocation test. As a result, both skin test and drug provocation have to be included for drug hypersensitivity investigation.
The 21 However, there is limited study reporting on the association of beta-lactaminduced immediate reaction and HLA class I genotype. The association with HLA-DRB1*09 and immediate hypersensitive reaction to penicillin has been reported in Chinese population. 22 However, we could not demonstrate the association between HLA-DRB1*09 and the BL-induced immediate hypersensitivity reaction. There were no children in the current study who developed immediate reaction from BL who carried HLA-DRB1*09. Since the HLA-B*48:01 allele frequency in Thai population is only 0.2% 23 and the BL-induced immediate hypersensitivity reaction ranging from acute urticaria to severe systemic allergic reaction or anaphylaxis. Based on our result, we would suggest using antibiotic other than beta-lactam antibiotics in Thai children who were known to carry HLA-B*48:01 for avoiding the severe immediate drug hypersensitivity reaction.
HLA-C*08:01 is a common allele in Thai population with the allele frequency of 15.75%. 24 HLA-C*08:01 was reported to be associated with co-trimoxazole-induced severe cutaneous reactions in HIV infected Thai adults. 24 We have shown the association of HLA-C*08:01 and the BL-induced delayed hypersensitivity reactions. HLA-C*08:01 allele frequency in our tolerant control is 3%, which is significantly lower than Thai general population (15.75%), this is the usual patterns of association where the pharmacogenetics risk increase frequency in case and decrease frequency in control groups, when compared with frequency in general population. The low allele frequency of HLA-C*08:01 in tolerant control may explain the reason why the significant association of HLA-C*08:01 and BL hypersensitivity was demonstrated only in the comparison with tolerant control but not in population control. We hypothesize that HLA-C*08:01 possibly be the risk allele for BL hypersensitivity. Since all tolerant control were challenged with BL, consequently children who carry at risk allele (such as HLA-C*08:01) would develop BL hypersensitivity and converted to cases group, resulting in the low HLA-C*08:01 allele frequency in our tolerant control. However, a further study with a larger number of children with BL hypersensitivity and tolerant control should be replicated to validate this observation.
We have shown the association of HLA-C*04:06 and BLinduced delayed hypersensitivity reactions. Two out of 10 children who had delayed hypersensitivity reaction from BL carried HLA-C*04:06 while only 1 in 93 tolerant control children carried this allele. However, there is no previous report on the association of HLA-C*04:06 and drug hypersensitivity. HLA-C*04:06 is an uncommon HLA allele in Thais and worldwide, HLA-C*04:06 allele frequency was reported as low as 0 to 0.82%. 25 The allele frequencies of HLA-DRB1*04:06 in Thai population were reported ranging from 0.2-4.3%. 25 A recent study has reported the association of HLA-DRB1*04:06 in statin-related myopathy in Japanese patients. 26 However, there is no previous report on the role of HLA-DRB1*04:06 and BL hypersensitivity reactions. We have demonstrated the associations of HLA-C*04:06, HLA-C*08:01 and HLA-DRB1*04:06 and the BL induced delayed hypersensitivity reactions. BL induced delayed hypersensitivity reactions is the T cell mediated drug hypersensitivity requiring T cell-HLA interaction. A recent study have demonstrated the shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity. 27 However, we did not evaluate for the similarities between binding specificities for our identified HLA risk alleles.
The 28 and for co-trimoxazole-induced severe cutaneous reaction 24 in Thailand. Since BL is commonly used for the treatment of respiratory tract infections. It is high possibility that our enrolled patients had been prescribed with other cold medicines along with BL resulting the association of these haplotypes and BL hypersensitivity in the current study.
The strength of our study is that all of BL hypersensitivity cases except for BL induced SCARs underwent investigation for drug hypersensitivity including skin test and drug provocation test and all of the control cases were BL tolerant control. However, our study still has limitations. Firstly, we have enrolled a limited number of SCARs. Secondly, there were no BL tolerant control children carried HLA-B*48:01, and HLA-DRB1*04:06 alleles due to these HLA alleles are uncommon in Thais which may have an effect on the wide range of 95%CI for these two alleles. A larger sample size in both case and tolerant control may be needed to validate our result.
In conclusion, we have shown that true BL hypersensitivity is approximately 10% in children with history of BL hypersensitivity. HLA-B*48:01, HLA-C*04:06, HLA-C*08:01 and HLA-DRB1*04:06 may be associated with the BL hypersensitivity in Thai children. These findings highlight the potential role for HLA genotype in predicting the BL hypersensitivity in children.
